`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMMISSIONERFORPATENTS
`P.O. Box 1450
`Alexandria, Virginia 22313-1450
`www.uspto.gov
`
`APPLICATION NO.
`
`FILING DATE
`
`FIRST NAMED INVENTOR
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION NO.
`
`171705, 189
`
`03/25/2022
`
`Benjamin E. Merritt
`
`111552.8016.US03
`
`9367
`
`07/11/2023
`7590
`25096
`PERKINS COIE LLP - SEA General
`PATENT-SEA
`P.O. BOX 1247
`SEATTLE, WA 98111-1247
`
`EXAMINER
`
`VU, QUYNH-NHU HOANG
`
`ART UNIT
`
`PAPER NUMBER
`
`3783
`
`NOTIFICATION DATE
`
`DELIVERY MODE
`
`07/11/2023
`
`ELECTRONIC
`
`Please find below and/or attached an Office communication concerning this application or proceeding.
`
`The time period for reply, if any, is set in the attached communication.
`
`Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the
`following e-mail address(es):
`
`patentprocurement@perkinscoie.com
`
`PTOL-90A (Rev. 04/07)
`
`-1-
`
`Imperative EX1002
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`Ul\TfED STATES DEPA RTME'IT OF COMMERCE
`United States Patent and Trademark Office
`Adiliess. COMMISSIO'JER FOR PATENTS
`PO Box 1450
`Alexandria, Virgmia 22313-1450
`\VVi\V.USpto.gov
`
`APPLICATION NO.
`
`17/705,189
`
`ISSUE DATE
`
`11-Jul-2023
`
`PATENT NO.
`
`11697011
`
`PERKINS COIE LLP - SEA General
`PATENT-SEA
`P.O. BOX 1247
`SEATTLE, WA98111-1247
`
`EGRANT NOTIFICATION
`
`Your electronic patent grant (eGrant) is now available, which can be accessed via Patent Center at https://
`patentcenter .uspto.gov
`
`The electronic patent grant is the official patent grant under 35 U.S.C. 153. For more information, please visit
`https://www.uspto.gov/electronicgrants
`
`page 1 of 1
`
`-2-
`
`Imperative EX1002
`
`
`
`UNITED STATES PA TENT AND TRADEMARK OFFICE
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMMISSIONERFORPATENTS
`P.O. Box 1450
`Alexandria, Virginia 22313-1450
`www.uspto.gov
`
`APPLICATION NO.
`
`17/705,189
`
`ISSUE DATE
`
`07/11/2023
`
`PATENT NO.
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION NO.
`
`11697011
`
`l l 1552.8016.US03
`
`9367
`
`25096
`7590
`06/21/2023
`PERKINS COIE LLP - SEA General
`PATENT-SEA
`P.O. BOX 1247
`SEATTLE, WA 98111-1247
`
`ISSUE NOTIFICATION
`The projected patent number and issue date are specified above. The patent will issue electronically. The
`electronically issued patent is the official patent grant pursuant to 35 U.S.C. § 153. The patent may be accessed
`on or after the issue date through Patent Center at https://patentcenter.uspto.gov/. The patent will be available in
`both the public and the private sides of Patent Center. Further assistance in electronically accessing the patent,
`or about Patent Center, is available by calling the Patent Electronic Business Center at 1-888-217-9197.
`
`The USPTO is implementing electronic patent issuance with a transition period, during which period the
`USPTO will mail a ceremonial paper copy of the electronic patent grant to the correspondence address of
`record. Additional copies of the patent (i.e., certified and presentation copies) may be ordered for a fee from the
`USPTO's Certified Copy Center at https://certifiedcopycenter.uspto.gov/index.html. The Certified Copy Center
`may be reached at (800)972-6382.
`
`Determination of Patent Term Adjustment under 35 U .S.C. 154 (b)
`(application filed on or after May 29, 2000)
`
`The Patent Term Adjustment is O day(s). Any patent to issue from the above-identified application will include
`an indication of the adjustment on the front page.
`
`If a Continued Prosecution Application (CPA) was filed in the above-identified application, the filing date that
`determines Patent Term Adjustment is the filing date of the most recent CPA.
`
`Applicant will be able to obtain more detailed information by accessing the Patent Application Information
`Retrieval (PAIR) WEB site (http://pair.uspto.gov).
`
`Any questions regarding the Patent Term Extension or Adjustment determination should be directed to the Office
`of Patent Legal Administration at (571 )-272-7702. Questions relating to issue and publication fee payments should
`be directed to the Application Assistance Unit (AAU) of the Office of Patents Stakeholder Experience (OPSE),
`Stakeholder Support Division (SSD) at (571)-272-4200.
`
`IR103 (Rev. 10/09)
`
`-3-
`
`Imperative EX1002
`
`
`
`INVENTOR(s) (Please see PAIR WEB site http://pair.uspto.gov for additional inventors):
`
`Benjamin E. Merritt, San Clemente, CA;
`John C. Thress, Capistrano Beach, CA;
`Paul Lubock, Monarch Beach, CA;
`
`APPLICANT(s) (Please see PAIR WEB site http://pair.uspto.gov for additional applicants):
`
`Inari Medical, Inc., Irvine, CA;
`
`The United States represents the largest, most dynamic marketplace in the world and is an unparalleled location
`for business investment, innovation, and commercialization of new technologies. The USA offers tremendous
`resources and advantages for those who invest and manufacture goods here. Through SelectUSA, our nation
`works to encourage and facilitate business investment. To learn more about why the USA is the best country in
`the world to develop technology, manufacture products, and grow your business, visit SelectUSA.gov.
`
`IR103 (Rev. 10/09)
`
`-4-
`
`Imperative EX1002
`
`
`
`Receipt date: 04/22/2022
`
`Doc code: IDS
`Doc description: information Disclosure Statement (IDS) Filed
`
`PTO/SB!08a (01-10)
`Approved for use through 07/31120·12. 0MB 0651-0031
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Ac! of ·1995, no persons are required to rnspond !o a collection of inforniation uniess it contains a valid 0MB control number.
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPUCANT
`{Not for submission under 37 CFR 1.99}
`
`Application Number
`17 /705, 189 - Coni# 9367
`Filing Date
`March 25, 2022
`First Named Inventor
`Benjamin E. Merritt
`Art Unit
`Not Yet Assi~1ned
`Examiner Name
`Not Yet Assigned
`Attorney Docket Number -111552-8016.US03
`
`,.
`Change(s
`: a11
`: ;nt,
`to docume
`i
`/F.H/
`i
`:22
`12/22/20
`i
`
`20160206344
`
`07-21-2016
`
`Brnzzi et al.
`
`20160228134
`
`08-11-2016
`
`Martin et al.
`
`20160262790
`
`09-15-2016
`
`Rosenbluth et ai.
`
`20160287276
`
`20160367285
`20·170014560
`
`20170037548
`
`20170042571
`
`10-06-2016
`Gl:.i HI .!Q~ Q
`
`Cox et al.
`12/2016
`
`Sos
`
`01-19-2017
`
`Minskoff et al.
`
`02-09-2017
`
`02-16-2017
`
`Lee
`
`Levi
`
`20170058623
`
`03-02-2017
`
`Jaffrey et aL
`
`20170079672
`
`20170086864
`20170100142
`
`20170105743
`20110·105745
`
`20'170112513
`20170112514
`
`03-23-2017
`
`Quick
`
`03-30-2017
`
`Greenllaigh et al.
`
`04-13-2017
`
`Look et aL
`
`04-20-2017
`
`Vaie et al.
`
`04-20-2017
`
`Rosenbluth et aL
`
`07-11-2017
`
`Marchand et al.
`
`04-27-2017
`
`Marchand et al.
`
`227.
`
`228.
`
`229.
`
`230.
`
`:i31.
`
`232.
`
`233.
`
`234.
`
`235.
`
`236.
`
`237.
`
`238.
`
`239.
`
`:":'.40.
`
`24i.
`
`242.
`
`243.
`
`20170189041
`
`07-06-2017
`
`Cox et al.
`
`20170233908
`
`08-17-2017
`
`Kroczynski et aL
`
`20170265878
`
`20170303939
`20170303942
`
`20170303947
`
`20170303948
`20·170325839
`
`20170348014
`
`09-21-2017
`
`10-26-2017
`
`l'vlarc:hand et aL
`Greenllaigh et al.
`
`10-26-2017
`
`Greenhalgh et al.
`
`10-26-2017
`
`Greenhalgh et al.
`
`10-26-2017
`
`Wallace et aL
`
`11-16-2017
`
`Rosenbluth et ai.
`
`12-07-2017
`
`Wallace et aL
`
`20180042624
`
`02-15-2018
`
`Greenhaigh et al.
`
`20180042626
`
`20180064453
`
`20180064454
`
`02-15-2018
`
`Greenhaigh et al.
`
`03-08-2018
`
`03-08-2018
`
`Garrison et al.
`Losordo et al.
`
`20180070968
`
`03-15-2018
`
`Wallace et ai.
`
`20180092652
`20180·105963
`
`20·180125512
`
`04-05-2018
`
`04-19-2018
`
`Marchand et al.
`Quick
`
`05-10-2018
`
`Nguyen et ai.
`
`244.
`
`245.
`
`246.
`
`247.
`
`248.
`
`:":'.49.
`
`250.
`
`251.
`
`252.
`
`253.
`
`254.
`
`255.
`
`256.
`
`257.
`
`~~58.
`
`259.
`
`156650242.1
`
`19
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/Q.N.V./
`
`-5-
`
`Imperative EX1002
`
`
`
`Receipt date: 04/22/2022
`
`Doc code: IDS
`Doc description: information Disclosure Statement (IDS) Filed
`
`PTO/SB!08a (01-10)
`Approved for use through 07/31120·12. 0MB 0651-0031
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Ac! of ·1995, no persons are required to rnspond !o a collection of inforniation uniess it contains a valid 0MB control number.
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPUCANT
`{Not for submission under 37 CFR 1.99}
`
`Application Number
`17 /705, 189 - Coni# 9367
`Filing Date
`March 25, 2022
`First Named Inventor
`Benjamin E. Merritt
`Art Unit
`Not Yet Assi~1ned
`Examiner Name
`Not Yet Assigned
`Attorney Docket Number -111552-8016.US03
`
`Change(s
`:·a-pph
`i
`n1:,
`to docume1
`I
`/F.H/
`i
`l 2/22/2C ·22
`
`20150032144
`
`01-29-2015
`
`Holloway
`
`20150059908
`
`20150088190
`
`20150127035
`20150·133990
`
`20·1 50150672
`
`20150164523
`
`20150164666
`
`20150190155
`
`20150190156
`
`20150196380
`20150196744
`
`20150209058
`
`20150209165
`20·1 50238207
`
`20150250578
`
`03-05-2015
`
`Mollen
`
`03-26-2015
`
`Jensen
`
`05-07-2015
`
`Trapp et al.
`
`05-14-2015
`OE! 8~ i!8~ r
`06-18-2015
`
`Davidson
`
`Ma
`
`06/2015
`
`Brady et al.
`
`06-18-2015
`
`Johnson et al.
`
`07-09-2015
`
`07-09-2015
`
`07-16-2015
`0,4 es i!S~ 0
`07-30-2015
`
`Ulmlll
`
`Ulmlll
`
`Berrada et a!.
`
`Aboytes
`
`07/2015
`Ferrera et al.
`
`07-30-2015
`
`Grandfield et ai.
`
`08-27-2015
`
`Cox et al.
`
`09-10-2015
`
`Cook et al.
`
`194.
`
`195.
`
`196.
`
`197.
`
`198.
`
`1199.
`
`200.
`
`201.
`
`202.
`
`203.
`
`204.
`
`205.
`
`206.
`
`~~07.
`
`208.
`
`209.
`
`210.
`
`20150265299
`
`20150305756
`
`20150305859
`
`20150352325
`
`20150360001
`
`20150374391
`
`20160008014
`20·160022293
`
`20160058540
`
`20160074627
`
`20160106448
`
`20160106449
`201601·13663
`
`20160113664
`
`20160113665
`20160'113666
`
`20·160143721
`
`211.
`
`212.
`
`213.
`
`2'14.
`
`21 ~i.
`
`:":'.16.
`
`217.
`
`218.
`
`219.
`
`220.
`
`221.
`
`222.
`
`223.
`
`224.
`
`:":'.25.
`
`226.
`
`09-24-2015
`
`Cooper et al.
`
`10-29-2015
`
`Rosenbluth
`
`·10-29-2015
`
`12-10-2015
`
`12-17-2015
`
`12-31-2015
`
`08-09-2016
`
`01-28-2016
`
`Elier
`Quick
`
`Quick
`
`Quick
`
`Rosenbluth
`Dubrni et al.
`
`03-03-2016
`
`Don Michael
`
`03-17-2016
`
`Cottone
`
`04-21-2016
`
`Brady et al.
`
`04-21-2016
`
`Brady et al.
`
`04-28-2016
`
`Bmdy et al.
`
`04-28-2016
`
`Bmdy et al.
`
`04-28-2016
`
`04-28-2016
`
`Brady et al.
`Quick
`
`05-26-2016
`
`Rosenbluth
`
`18
`
`156650242.1
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/Q.N.V./
`
`-6-
`
`Imperative EX1002
`
`
`
`Receipt date: 04/22/2022
`
`Doc code: IDS
`Doc description: information Disclosure Statement (IDS) Filed
`
`PTO/SB!08a (01-10)
`Approved for use through 07/31120·12. 0MB 0651-0031
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Ac! of ·1995, no persons are required to rnspond !o a collection of inforniation uniess it contains a valid 0MB control number.
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPUCANT
`{Not for submission under 37 CFR 1.99}
`
`Application Number
`17 /705, 189 - Coni# 9367
`Filing Date
`March 25, 2022
`First Named Inventor
`Benjamin E. Merritt
`Art Unit
`Not Yet Assi~1ned
`Not Yet Assigned
`Examiner Name
`Attorney Docket Number -111552-8016.US03
`
`201303·17589
`
`11-28-2013
`
`Martin et al.
`
`20130345739
`
`12-25-2013
`
`Bmdy et al.
`
`20140005712
`
`01-02-2014
`
`Martin
`
`20140005713
`
`01-02-2014
`
`Bowman
`
`20140005715
`20·140005717
`
`20140025048
`
`Castei!a et al.
`
`03-31-2015
`01-02-2014
`
`l\t1a1iin et al.
`01-23-2014 Ward
`
`20140031856
`
`01-30-2014
`
`Martin
`
`20140046133
`
`02-13-2014
`
`Nakamura et al.
`
`20140046243
`
`02-13-2014
`
`Ray et al.
`
`20140121572
`
`05-01-2014
`
`Folk
`
`20·140155830
`
`06-05-2014
`
`Bonnette et al.
`
`20140155908
`
`07-22-2014
`
`Rosenbluth et al.
`
`20140155980
`
`20140180397
`20140188143
`
`06-05-2014
`O~-f.'l~-~O I ~
`Ci~ 6!;-~0 l !l
`
`Turjrnan
`
`Gerberding et al.
`
`Martin et al.
`
`06/201+
`07/201+
`
`161.
`
`162.
`
`16:t
`
`164.
`
`165.
`
`166.
`
`167.
`
`1trn.
`
`169.
`
`170.
`
`171.
`
`172.
`
`173.
`
`174.
`
`I- ~75.
`176.
`
`177.
`
`I
`Change(s
`r r
`l
`to docum 1"",
`/F.H/
`i
`l 2/22/2C 22
`
`178.
`
`179.
`
`180.
`
`181.
`
`182.
`
`183.
`
`184.
`
`185.
`
`186.
`
`187.
`
`188.
`
`189.
`
`190.
`
`191.
`
`192.
`
`193.
`
`20140236219
`
`08-21-2014
`
`Dubrul et al.
`
`20140243882
`
`08-28-2014
`
`Ma
`
`20140257253
`
`09-11-2014
`
`Jemison
`
`09-18-2014
`10-30-2014
`
`()€1,,€,~-~0T:i
`
`20140276403
`20 ·1 40318354
`
`20140324091
`
`20140330286
`
`20140336691
`
`Thompson et ai.
`Rosenbluth 10/201+
`11-06-2014 Wallace et al.
`·11-13-2014
`
`Follmer et aL
`
`Jones et al.
`
`20140343593
`
`11-20-2014
`
`Chin et ai.
`
`20140364896
`
`12-11-2014
`
`Consigny
`
`20140371779
`
`12-18-2014
`
`Vale et al.
`
`20150005781
`
`20150005792
`20·150018859
`
`20150018850
`
`20150018929
`
`01-01-2015
`0·1-01-2015
`
`~ Hi ~el!~
`
`01-15-2015
`
`01-15-2015
`
`20150025555
`
`01-22-2015
`
`Lund-Clausen et al.
`
`Ahn
`Quick
`
`Quick
`
`01/2015
`
`Martin et al.
`sos
`
`17
`
`156650242.1
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/Q.N.V./
`
`-7-
`
`Imperative EX1002
`
`
`
`Receipt date: 04/22/2022
`
`Doc code: IDS
`Doc description: information Disclosure Statement (IDS) Filed
`
`PTO/SB!08a (01-10)
`Approved for use through 07/31120·12. 0MB 0651-0031
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Ac! of ·1995, no persons are required to rnspond !o a collection of inforniation uniess it contains a valid 0MB control number.
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPUCANT
`{Not for submission under 37 CFR 1.99}
`
`Application Number
`17 /705, 189 - Coni# 9367
`Filing Date
`March 25, 2022
`First Named Inventor
`Benjamin E. Merritt
`Art Unit
`Not Yet Assi~1ned
`Not Yet Assigned
`Examiner Name
`Attorney Docket Number -111552-8016.US03
`
`128.
`
`129.
`
`130.
`
`131.
`
`132.
`
`133.
`
`134.
`
`135.
`
`136.
`
`137.
`
`138.
`
`139.
`
`140.
`
`141.
`
`142.
`
`143.
`
`20110288529
`
`11-24-2011
`
`Fulton
`
`20110288572
`
`20110319917
`
`11-24-2011
`
`12-29-2011
`
`Martin
`Ferrera et al.
`
`20120059309
`
`03-08-2012
`
`di Palma et al.
`
`20120059356
`20·120083824
`
`20120083868
`
`20120089216
`
`20120101480
`
`03-08-2012
`
`04-05-2012
`
`di Palma et al.
`Berrada et ai.
`
`04-05-2012
`
`Shrivastava
`
`04-12-2012
`
`04-26-2012
`
`Rapaport et al.
`Ingle et al.
`
`20120101510
`
`04-26-2012
`
`Lenker et al.
`
`20120138832
`
`20120143239
`
`20120165919
`20120'17918'1
`
`20·120197277
`
`20120232655
`
`06-07-2012
`
`06-07-2012
`
`Townsend
`Aklog et al.
`
`06-28-2012
`
`Cox et al.
`
`07-12-2012
`
`Straub et al.
`
`08-02-2012
`
`09-13-2012
`
`Stinis
`Larrison et al.
`
`144.
`
`145.
`
`146.
`
`147.
`
`) ann!it J48.
`Change(s
`to docum L+
`149.
`i
`/F.H/
`C!z::-2.
`12/22/2
`
`150.
`
`15i.
`
`152.
`
`153.
`
`154.
`
`155.
`
`156.
`
`157.
`
`158.
`
`159.
`
`160.
`
`156650242.1
`
`20120271105
`
`10-25-2012
`
`Nakamura et aL
`
`20120271231
`
`20120277788
`201203'10166
`
`20130030460
`
`20130046332
`
`20130066348
`20·1 30092012
`
`20130096571
`
`10-25-2012
`·11-01-2012
`
`Agrawal
`
`Cattaneo
`
`Huff
`12-06-2012
`01-31-201.l 3 Marks et al.
`02-21-2013
`Jones et al.
`
`03-14-2013
`
`Fiorella et al.
`
`04-18-2013
`
`04-18-2013
`
`Marchand et al.
`Massicotte et al.
`
`20130102996
`
`04-25-2013
`
`Strauss
`
`20130116721
`
`20130144326
`
`20130165871
`
`r,.M, - -
`
`05-09-2013
`-
`06-27-2013
`
`V
`
`20130184703
`
`07-18-2013
`
`Takagi et al.
`
`Brady et al.
`
`06/2013
`
`Fioreiia et al.
`Shireman et aL
`
`20130197567
`
`20130226196
`20·130289608
`
`08-01-2013
`
`Brady et al.
`
`08-29-2013
`
`Smith
`
`10-31-2013
`
`Tanaka et ai.
`
`16
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/Q.N.V./
`
`-8-
`
`Imperative EX1002
`
`
`
`Docket No.: l l 1552-8016.US03
`(PATENT)
`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`In re Application of:
`Benjamin E. Merritt et al.
`
`Application No.: 17 /705, 189
`
`Confirmation No.: 9367
`
`Filed: March 25, 2022
`
`Art Unit: 3783
`
`For: HEMOSTASIS VALVES AND METHODS OF
`USE
`
`Examiner: Quynh-Nhu H. Vu
`
`COMMENTS ON STATEMENT OF REASONS FOR ALLOWANCE
`
`Commissioner for Patents
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`Dear Commissioner:
`
`In the Notice of Allowability mailed on December 14, 2022 and on April 14, 2023, the
`
`Examiner allowed claims 1-9. The Applicant acknowledges Examiner's statements of Reasons
`
`for Allowance of the above-referenced patent application and agrees that the claimed subject
`
`matter is patentable. However, the Applicant takes no position regarding the Reasons for
`
`Allowance presented by the Examiner other than the positions Applicant may have previously
`
`taken during prosecution. Therefore, the Examiner's Reasons for Allowance should not be
`
`attributed to the Applicant as an indication of the basis for Applicant's belief that the claims are
`
`patentable. Furthermore, the Applicant respectfully asserts that there may also be additional
`
`reasons for patentability of the claimed subject matter not explicitly stated in this record and the
`
`Applicant does not waive its rights to such arguments by not further addressing such reasons
`
`herein.
`
`160391031.1
`
`-1-
`
`-9-
`
`Imperative EX1002
`
`
`
`Application No.: 17/705,189
`Comments on Statement of Reasons for Allowance
`
`Docket No.: ll 1552-8016.US03
`
`Dated: May 25, 2023
`
`Respectfully submitted,
`
`By _/Matthew S. Williams/ _ _ _ _
`Matthew S. Williams
`Registration No.: 77,516
`
`Perkins Coie LLP
`P.O. Box 1247
`Seattle, WA 98111-1247
`Phone: (206) 359-3343
`Fax: (206) 359-7198
`
`Attorney for Applicant
`
`160391031.1
`
`-2-
`
`-10-
`
`Imperative EX1002
`
`
`
`PAR.TB~_FEE(S) TRANSMffTAL
`Complete and send this form. together with the applicable fee(s), by mail or fax. orv ia EFS-Web.
`By mail, send to:
`1fail Stop ISSUE FEE
`Commissioner for Patents
`P.O. Box 1450
`Alexandria, VA 22313-1450
`INSTRUCTIONS: 111isJimn should be used for transmitting the ISSUE FEE andl'OBLICAI1ON FEE (ifrequired). Blocks l through5 shou!dbecon:i:,leted where appropriate.
`All f,.uther correspondence incJudingthe Patent advance orders and notification ofrmintenance fues vnH be rrfliled to the cun-ent correspondence address as indicated unless
`corrected belo'.v or directed othcnvist: in Bjock 1 ) by (a) ~~pcci!)'ing a nt:'.v correspondence address: and/or \b) indicating a separntc "FEE ADDRESS" for rraintt:nance foe
`notLficatjon:>.
`CTJR..'<.ENT CORRESPONDENCE ADDRESS (Nom: l/,e Block l furany change ofaddrcss)
`25096
`Perkins Coie LLP
`P.O. Box 1247
`PATENT-SEA
`Seattle, WA, 98111-1247
`us
`
`By fax. send to:
`
`( 57 l) 273-2885
`
`Nott:: A certificate of rn:1iling can only bt: used for don--cstic ffflHings of tht:
`Fct:(s) Trnnsrni.ttal. T11is certi:ticatc cannot be used for any other accon.panying
`paIJ'-''.fS. Each addjtional pap~;r, such as an ossi.gnnK>rH or fo;nul drawing. nust
`havf its O\Vll certificate of nniling or transmission.
`Cniifirnt~ of Mailing orTnm~mis~ion
`I hereby certir1 that this Fee(s) Transmittal is being deposited with the UnitEXl
`States Postal Service with sufficient postage for .first class rrnil in an envelope
`addressed to the l\:f.aH Stop lSSTJE FEE addrt=~~satHYve. orbdng rnrnsmitted to tli:
`lJSPTO ·vi,:1 EFS-VVeb or by fac~~imik: tt• (57 l) 2 7i-?.885 t•n the datt: bcJow
`. .
`JiYoung Anderson
`/JiYoung Anderson/
`2023-05~25
`
`(Typed orprinted rc.rre)
`
`\Signature)
`
`(Date)
`
`ATTORNEY DOCKET NO
`APPLICATION NO
`HLINGDATE
`FIRST NA!v!ED INVENTOR
`111552-8016.US03
`17/705,189
`March 25, 2022
`Benjamin E. Merritt
`TIILEOFIN\iENTION HEMOSTASIS VALVES AND METHODS OF USE
`
`CONHRNIATJON NO
`9367
`
`APPLN. 'JYPE
`UTILITY
`
`ENTITY STATUS
`LARGE
`
`ISSUE FEE DUE
`1200
`
`PUBLl ATH. N FEE DUE
`0
`
`PREV. PAID bSUE FEE
`0
`
`Tl TAL FEE< SJ DUE
`1200
`
`DATE DUE
`2023-07-14
`
`Quynt1-Nhu Vu
`
`EXAMINER
`
`ARTUNJT
`OPAP
`
`CI,ASS-SUBCLASS
`
`1. Change of correspondence address or indication of .. Fee
`Address" t37 (~FR l.363)
`D Change of correspondence address (or Change of
`Corrnspondt:nce Add.ms~~ form PTO/SB/1 !.2) attached.
`D" Fee Address" indicatmn (or" Fee Address'' Indication
`funn PTO/SB/47, Rev 03-09 ornure recent)
`at:.ar;hed. u~cof a Custom~rNmnberi, n·quircd.
`
`2. For printing on the patent front page. list
`
`I)) The rrnnx:s of up to 3 regi~~ternd patt:nt attorneys
`or;;gr;nts OR, altemativdy,
`(!.) The nanx: of3 sjngleflnn(having as amenbt:r
`a ;~'.gi:>tered aHorn~'.Y or agent) and. Hw n~nn::> of
`up to 2 registered patent attorneys or agents. If
`no nan~ is listed, no na:n.J; will be printed.
`
`3.
`
`ASSIGNEE NAJVlE AND RESIDENCE DATA TO BE PRINTED ON ·111E PAIENT(print or type)
`
`1. Perkins Coie LLP
`
`2.
`
`PLEASE NOTE: lJnlt=~~s an assignee is idenrilied bdow. no assignee data will 3ppcar on tht: parent. Ifan assignee is idt:ntincd bt:low, the docunx:nt rrusr have bt:en
`pn;;viously rr.::cord~;(t or JH~;d for recordatjvn, as set ibrth jn 37 CFR 3 .J J ;rnd 37 CFR 3 .8 l{a\ Coni1lt:tion oft.hjs form js NOT a substituh: for JHing an assigm:rent.
`\Al NAME OF ASSIGNEE
`(B) RESIDENCE. (CITY and STATE or COUNTRY)
`Irvine, CA
`lnari Medical, Inc"
`
`Please check the appropriate assignee category or categories (will not be printed on the patent): D Individual [Z] Corporation orotherprivate group entity D Govemrren(
`@Issue Fee D PublicmionFee (ifreqmred, D Advance Order· # of Copies _
`4a. Fees Submitted:
`4b. I'viethod of Payrr.ent tP!r:asefirsl reapp~\' any prev1ov.slypaid fee sh0vn above):
`0Endosed cht:ck D Non-t:lixtronic payn:i:nt by credit card (Attach fonnPID-2038)
`IZJ Electronic Payn--cntvia EFS-\rVeb
`IZ] 'Jhe Director is hereby authorized to charge the required :fue(s), any deficiency. orcred1t any ove11-1ayment to Deposit Account No. --~~~g_?~~) __ _
`
`5 Change of Entity Status (from status indjcaled obove)
`D Applicant certi~ying micro entity status. See 37 CFR 1.29.
`D App]icant asst:rting ~~rraH entity srnrus. See 3 7 CFR 1.2 7
`D Applicant changing to reguJarund1scoum:ed fee status.
`
`NO'IE: Absent a valid Certification ofMicro Entity Status (see Jomi,; PTOISB/15A and 15B), issue Jee
`paynli:nt in the mcn:.i ent1ty 3m:)Unt vnH not be accepted at the risk ofappJication abandonrrent.
`
`NOTF~· If the application w:x~ prc,dously under micro enOty ~Hatus, checkLng this hox'.viU bt: taken as
`a notification ofloss ofentitlerrent to micro entity status.
`
`NOTE: Checking this box will be taken as a notificatrnnofloss ofentitlerrem to s:rall or micro entity
`:;tatus. as applicabk
`
`NOIE: This form n11~~t be signed in accord,:1nct: with 37 CFR 1.31 ,:1nd l.33. St:e 37 CFH l.4 for sjgnature rcquiren:i:nts and certincations.
`
`Authorized Signature
`
`/Matthew S. Williams/
`
`'l~ypfd or printed nan~
`
`Matthew S" Williams
`
`Date 2023-05-25
`Registration No. 77,516
`
`PTOL-85 Pmt B (08-l 8) Approved for ust: through 03/3 l/20!.3
`
`0MB 0651~0033
`
`l/_S_ Pmem and Tradcm:uk O1licc: U.S DEPA R11viENT OF COMMERCE
`
`-11-
`
`Imperative EX1002
`
`
`
`0MB Clearance and PRA Burden Statement for PTOL-85 Part B
`
`The Paperwork Reduction Act (PRA) of 1995 requires f-ederal agencies to obtain Office of Management and Budget a pprova I before requesting
`most types ofinforrnation from the public. When 0MB approves an agency requestto collect information from the public, 0MB (i) provides a
`valid 0MB Control Number and expiration date for the agency to display on the instrun,entthat will be used to collect the information and (ii)
`requires the agency to inform the public a bout the 0MB Control Number's lega I significance in accordance with 5 CFR 1320.5{b).
`
`The information collected by PTOL-85 Part Bis required by 37 CFR 1.311.. The information is required to obtain or retain a benefit by the public
`which is to file (and by the USPTO to process) an application.Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This collection is
`estimated to take 30 minutes to complete, including gathering, preparing, and submitting the completed application form to the USPTO. Time will
`vary depending upon the individua I case. Any comments on the a mount ofti me you require to complete this form and/or suggestions for
`reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and Trademark Office, U.S. Department of Commerce, P .0. Box
`1450, Alexandria, Virginia 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, P.O.
`Box 1450, Alexandria, Virginia 22313-1450. Under the Paperwork Reduction Act of1995, no persons a re required to respond to a collection of
`information unless it displays a valid 0MB control number.
`
`Privacy Act Staternent
`
`The Privacy Act of 1974 (P.L. 93-579} requires that you be given certain information in connection with your submission of the attached form
`related to a pa tent application or pa tent. Accardi ngly, pursuant to the require men ts of the Act, please be advised that: (1) the genera I authority
`for the collection of this information is 35 U.S.C. 2(b)(2); (2)furnishingofthe information solicited is voluntary; and (3)the principal purpose for
`which the information is used by the U.S. Patent and Trademark Office is to process and/or examine your submission re lated to a patent
`application or patent. If you do not furnish the requested information, the U.S. Patent and Trademark Office may not be able to process and/or
`examine yours ubmission, which may res ult in termination of proceedings or abandonment oft he application or expiration of the patent.
`
`The information provided by you in this form will be subjectto the following routine uses:
`
`1. The information on this form will be treated confidentially to the extent allowed under the Freedom of lnforrnation Act (5 U.S.C. 552)
`and the Privacy Act {5 U.S.C 552a ). Records from this system ofrecords may be disclosed to the Department of Justice to determine
`whether disclosure of these records is required by the Freedom of Information Act,
`2. A record from this sys ten, of records n,ay be disclosed, as a routine use, in the course of presenting evidence to a court, magistrate, or
`a dmi nistra t ive t ri buna I, including disclosures to opposing counsel in the course of settlement negotiations.
`3. A record in this system ofrecords may be disclosed, as a routine use, to a Member of Congress submitting a request involving an
`individua!, to whom the record pertains, when the individual has requested assistance from the Member with respect to the subject
`matter oft he record.
`4. A record in this system ofrecords may be disclosed, as a routine use, to a contractor of the Agency having need for the information in
`order to perform a contract. Recipients of information shall be required to comply with the requirements of the Privacy Act of 1974, as
`amended, pursuant to 5 U.S.C. '.,52a(m).
`5. A record related to an international Application filed under the Pa tent Cooperation Treaty in this system of records may be disclosed, as
`a routine use, to the International Bureau of the World Intellectual Property Organization, pursuant to the Patent Cooperation Treaty.
`6. A record in this systern of records rnay be disclosed; as a routine use; to a not her fed era I agency for purposes of Nationa I Security revie\,v
`(35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C. 218(c)}.
`7. A record from this system of records may be disclosed, as a routine use, to the .<\dministrator, General Services, or his/her designee,
`during an inspection ofrecords conducted by GSA as pa rt of that agency's responsibility to recommend improvements in records
`management practices and programs, under authority of 44 U.5.C. 2904 and 2906. Such disclosure sha II be made in accorda nee with the
`GSA regulations governing inspection of records for this purpose, and any other relevant (i.e., GSA or Commerce) directive. Such
`disclosure shall not be used to make determinations about individuals.
`8. A record from this system ofrecords may be disclosed, as a routine use, to the public after either publication oft he application pursuant
`to 35 U.S.C. 122(b)orissuance ofa patent pursuant to 35 U.S.C.151. Further,a record may be disclosed,subject to the limitationsof37
`CFR 1.14, as a routine use, to the public ifthe record was filed in an application which became abandoned or in which the proceedings
`we re terminated and which application is referenced bye ithe r a published application, an application open to public inspection or an
`issued patent.
`9. A record from this system ofrecords may be disclosed, as a routine use, to a Federal, State, or local law enforcement agency, if the
`USPTO becomes aware ofa violation or potentia i violation of law or regulation.
`
`-12-
`
`Imperative EX1002
`
`
`
`: >~ PATENT ANO TRADEMARK OFFICE
`
`1 _ r:1.im·· UNITED STATES
`
`Page 1 of 2
`PO Bo:< 1450
`Alexand,ia. VA 223, 3 - 1450
`VV'vV""./'/.USpto,go\/
`
`ELECTRONIC ACKNOWLEDGEMENT RECEIPT
`
`APPLICATION #
`17/705,189
`
`RECEIPT DATE/ TIME
`05/25/2023 02:26:32 PM ET
`
`ATTORNEY DOCKET#
`111552.8016.US03
`
`Title of Invention
`HEMOSTASIS VALVES AND METHODS OF USE
`
`Application Information
`
`APPLICATION TYPE Utility - Nonprovisional Application
`under 35 USC 111 (a)
`
`PATENT#
`
`-
`
`CONFIRMATION# 9367
`
`FILED BY
`
`JiYoung Anderson
`
`PATENT CENTER# 62155578
`
`FILING DATE 03/25/2022
`
`CUSTOMER# 25096
`
`CORRESPONDENCE
`ADDRESS
`
`-
`
`Documents
`
`FIRST NAMED Benjamin E. Merritt
`INVENTOR
`
`AUTHORIZED BY Matthew Williams
`
`TOTAL DOCUMENTS: 2
`
`DOCUMENT
`
`PAGES
`
`DESCRIPTION
`
`SIZE {KB)
`
`2
`
`Issue Fee Payment (PTO-85B)
`
`252 KB
`
`Miscellaneous Incoming Letter
`
`88 !<B
`
`2023-5-25 lssue Fee Trans -
`111552-8016US3. PDF
`
`22023--5-25 Comments··
`·1 i 552-80 i GUS3. PDF
`·1
`
`Digest
`
`DOCUMENT
`
`2023-5-25 !ssue Fee Trans -
`11 i 552--B0i 6US3. PDF
`
`CFC2608DA0B061 C8C556CA8824C8085 ·1301 ADCCE0 1895DED
`A9F51565FF5099C8127B3C100C051D8707BEECB05051FA5D
`
`-13-
`
`Imperative EX1002
`
`
`
`942FBDED2B0DD4CD2C387F46FC0232AD
`
`Page 2 of 2
`
`22023-5-25 Comments -
`11 i 552-S0i 6US3. PDF
`
`0FE388318E4ABEA4708245C16AC1D63F2F2FE6CA8EE87172E
`C288424460CF522BEF66i90BFF3D1DO68022090BB2FD29E81
`E1385037FB6A2E256C6913E388AB0B
`
`Tr1is Ackr.owledgernent Receipt evidences receipt on Fie noted date by Fie USPTO ol the ind,cated documents, ch;:U"ac!e,ized
`tiy t:1e applicant, and including page counts, vvl1ere app!icab!e. It serves as evidence of receipt sin1ilar to a Post Carel, as
`described in MPEP 503.
`
`New Applications Under 35 ll.S.C. 111
`If a new application is being filed and the application inc!ucies the necessary components for fi!inq date (see 37 CFR 1.53/b)·(d)
`and fvlPEP 506), a Filino Receipt (37 CFR 1.541 wil! be issued in due course and the date shovvn on this .Acknowledoemer1t
`Hece,pt w:11 ;:istabiish the liling date ol the a.pplica!ion
`
`Ni:itlona! Sti:ige of an !ntemationa! App!!cation under 35 UaS.C. 371
`If a timeiy submission to enter the nationa! stage of an international application is compliant vvith the conditions of 35 U.S.C.
`37·1 and other a.pplicable require,,1ents a Fon,1 PCT!DO/EO/903 ind,cating acceptance ol the applicat,on as a national stage
`subn1ission uncler 35 U.S.C. 37"1 will be issued in addition to tl1e Fiiing Receipt, in ciue course.
`
`If a new ,ntemationai app:ication is being f:led ,:1no !he interna!iona, application includes the necessa:y components for an
`international fi!inq ciate (see PCT .Article 11 ancl MPEP 1B10), a t"1otification of the International Application f\Jumber and of the
`International Filing Da!e (Form PCTiRO/105) will be ,ssued in due course, subject to prese:iptions concemir.g national secur:ty,
`and !:7::i date s:1own on this Acknovvl,,,dgement ,-"\eceipt will establish the int::Hnationa, liling date ol the applica!ion.
`
`-14-
`
`Imperative EX1002
`
`
`
`: >~ PATENT ANO TRADEMARK OFFICE
`
`1 _ r:1.im·· UNITED STATES
`
`Page 1 of 2
`PO Bo:< 1450
`Alexand,ia, VA 223, 3 - 1450
`VV'vV""./'/.USpto,go\/
`
`ELECTRONIC PAYMENT RECEIPT
`
`APPLICATION #
`17/705 1189
`
`RECEIPT DATE/ TIME
`05/25/2023 02:26:32 PM ET
`
`ATTORNEY DOCKET#
`111552.8016,US03
`
`Title of Invention
`HEMOSTAS!S VALVES AND METHODS OF USE
`
`Application Information
`
`APPLICATION TYPE Utility - Nonpmvisional Application
`unde, 35 USC 11 ·, (a)
`
`PATENT#
`
`-
`
`CONFIRMATION# 9367
`
`FILED BY
`
`,JiYoung Anderson
`
`PATENT CENTER# 62.155578
`
`AUTHORIZED BY Matthew Willimr.s
`
`CUSTOMER# 25096
`
`FILING DATE 03/25/2022
`
`CORRESPONDENCE
`ADDRESS
`
`-
`
`Payment Information
`
`FIRST NAMED Benjamin E. Merritt
`INVENTOR
`
`PAYMENT METHOD
`CARD/ 3369
`
`PAYMENT TRANSACTION ID
`E202350E27386554
`
`PAYMENTAUTHOR~EDBY
`JlYoung Anderson
`
`FEE CODE
`
`DESCRIPTION
`
`ITEM PRICE($)
`
`QUANTITY
`
`ITEM TOT AL($)
`
`UTILITY ISSUE FEE
`
`1200.00
`
`TOTAL AMOUNT:
`
`$1,200,00
`
`This .Adqmwlednermmt Receipt evidences :eceipt on the noted date by the USPTO of the indicated documents, characterized
`by the applirnnt, and including page counts, where appiicabie. It serves as evidence of rnce:pt sini:lar to a Post CHrd, as
`described in MPEP 50:3.
`
`If a new Hpplica!ion is be:ng filed and the application inciudes !he necessary components for fiiing date (see 37 Cf-:R 1 .53(bHd)
`and [\/1PEP 506), a Filing Receipt (37 CFR 154) wili be issued in due course and the Cate sllm,vn on



